Industry Seeks Power To Trigger Safety Labeling Changes Under FDAAA

Seeking to turn the regulatory burdens imposed by the FDA Amendments Act to their advantage, pharmaceutical manufacturers are asking the agency to give sponsors the power to trigger safety-related labeling changes under the statute.